Ubs Group Ag Zivo Bioscience, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$2.33 - $3.64 $2,143 - $3,348	-920 Reduced 51.98%	850 $2,000
Q4 2022 Feb 08, 2023	BUY	$2.48 - $19.98 $4,389 - $35,364	1,770 New	1,770 $4,000
Q2 2022 Aug 10, 2022	SELL	$2.61 - $4.03 $8,184 - $12,638	-3,136 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.44 - $4.27 $3,513 - $6,148	-1,440 Reduced 31.47%	3,136 $12,000
Q4 2021 Feb 14, 2022	BUY	$2.73 - $4.48 $6,723 - $11,034	2,463 Added 116.56%	4,576 $13,000
Q3 2021 Nov 15, 2021	BUY	$2.8 - $5.45 $5,916 - $11,515	2,113 New	2,113 $10,000

Ticker ZIVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,419,660
Market Cap $164M
Description
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietar...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.